Relationship Between Aflatoxins and Hepatitis B Among Patients with Liver Disease at Moi Teaching and Referral Hospital, Uasin Gishu County

Main Article Content

Florence Chelimo Goren https://orcid.org/0000-0002-3599-010X
Odip Osano https://orcid.org/0000-0001-9542-9798
Judith Khazenzi

Keywords

Aflatoxin B1, Hepatitis B virus (HBV), Hepatocellular carcinoma (HCC), Liver disease, Aflatoxin-lysine adduct, Co-exposure, MTRH, Kenya

Abstract

Liver disease is a major public health concern in Kenya, where hepatocellular carcinoma (HCC) is strongly associated with chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxins. The relationship between aflatoxin exposure and HBV remains insufficiently studied, limiting targeted prevention and management of liver disease. This study aims to establish relationship between aflatoxins and hepatitis B among patients with liver diseases at Moi Teaching and Referral Hospital, Uasin Gishu County. The study adopted a cross sectional descriptive study. Blood sample was collected in clot activated tubes for aflatoxin and hepatitis profile tests and the serum was separated and stored at -20°c for both male and female patients admitted in wards or visiting various clinics for diagnosis. Treatment or recovery regiments were selected through their case history and lab-diagnosis results of hepatitis profile, liver function tests (LFTs), AFP and histology. Conditional logistic regression was used to explore the relationship between aflatoxin B1-lysine and hepatitis B surface antigen titers in serum. Findings showed that the prevalence of Hepatitis B in Moi Teaching and Referral Hospital (17%) is higher than the national prevalence of 13.8%. The results suggest that older adults are more likely to be affected by Hepatitis B. However, the study found no significant difference in Hepatitis B prevalence between men and women. The results also showed mean value of 26.7289 pg/2g of aflatoxin exposure among the patients. Conditional logistic regression indicated that aflatoxin is associated with an increase in the log-odds of developing hepatitis B (χ² = 1.513 and a p-value = 0.009, p < 0.05). This suggests that high levels of aflatoxin cause hepatitis B.  Based on these findings, a pressing need exists to amplify public health campaigns that foster heightened awareness about both Hepatitis B and aflatoxin exposure. It is also imperative to establish standardized and routine screening protocols specifically aimed at identifying Hepatitis B among individuals presenting with symptoms of liver disease. Equally significant is the proactive approach towards monitoring aflatoxin exposure among individuals displaying symptoms of liver disease. To this end, the implementation of systematic screening protocols tailored to aflatoxin exposure is paramount.

Downloads

Download data is not yet available.
Abstract 39 | PDF Downloads 18

References

Afum, C., Cudjoe, L., Hills, J., Hunt, R., Padilla, L. A., Elmore, S., ... & Jolly, P. E. (2016). Association between aflatoxin M1 and liver disease in HBV/HCV infected persons in Ghana. International Journal of Environmental Research and Public Health, 13(4), 377. https://doi.org/10.3390/ijerph13040377

Akoth, A. J. (2021). Prevalence and factors associated with hepatitis B and human immunodeficiency virus co-infection among blood donors in Kenyan Coastal Region (Doctoral dissertation, Jomo Kenyatta University of Agriculture and Technology). JKUAT-COHES Repository.

Alsulaimany, F. A. (2023). Overview of Hepatitis B virus (HBV) infection. Journal of King Abdulaziz University: Science, 33(1).

Alvarez, C. S., Egner, P. A., Wang, J. S., Lindshield, B. L., & Gadgil, M. (2020). Aflatoxin exposure in Guatemala. In Aflatoxins: Finding solutions for improved food safety (pp. 45–58). International Food Policy Research Institute. https://cgspace.cgiar.org/server/api/core/bitstreams/0ae65be1-601e-4427-8243-557c1e3d6ad8/content

Amponsah-Dacosta, E. (2021). Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World Journal of Gastroenterology, 27(36), 6025. https://doi.org/10.3748/wjg.v27.i36.6025

Azziz-Baumgartner, E., Lindblade, K., Gieseker, K., Rogers, H. S., Kieszak, S., Njapau, H., ... & Aflatoxin Investigative Group. (2005). Case–control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environmental Health Perspectives, 113(12), 1779–1783. https://doi.org/10.1289/ehp.8384

Batool, S., Morton Cuthrell, K., Tzenios, N., & Shehryar, Z. (2022). Hepatocellular carcinoma in non-alcoholic fatty liver disease: Emerging burden. International Research Journal of Oncology, 6(4), 93–104. https://hal.science/hal-05195325/

Cao, J., & Wang, W. (2014). Effects of astaxanthin and esterified glucomannan on hematological and serum parameters, and liver pathological changes in broilers fed aflatoxin-B1-contaminated feed. Animal Science Journal, 85(2), 150–157. https://onlinelibrary.wiley.com/doi/abs/10.1111/asj.12103

Capuozzo, M., Santorsola, M., Bocchetti, M., Perri, F., Cascella, M., Granata, V., ... & Ottaiano, A. (2022). p53: From fundamental biology to clinical applications in cancer. Biology, 11(9), 1325. https://doi.org/10.3390/biology11091325

Cary, J. W., Gilbert, M. K., Lebar, M. D., Majumdar, R., & Calvo, A. M. (2018). Aspergillus flavus secondary metabolites: More than just aflatoxins. Food Safety, 6(1), 7–32. https://doi.org/10.14218/FSS.2017.00007

Chen, C. J., Wang, L. Y., Lu, S. N., Wu, M. H., You, S. L., Zhang, Y. L., ... & Santella, R. M. (1996). Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology, 24(1), 38–42. https://doi.org/10.1002/hep.510240108

Chen, T., Liu, J., Li, Y., & Wei, S. (2022). Burden of disease associated with dietary exposure to aflatoxins in China in 2020. Nutrients, 14(5), 1027. https://www.mdpi.com/2072-6643/14/5/1027

Cherotich, C., Okoth, M. W., Abong', G. O., Kariuki, S. W., & Omuse, E. R. (2025). Aflatoxin prevalence and association with maize grain physical and nutritional qualities in the informal markets in Meru County, Kenya. African Journal of Food, Agriculture, Nutrition and Development, 25(2), 25520–25537. https://thehive.icipe.org/all-prp/1080/

Chu, Y. J., Yang, H. I., Wu, H. C., Liu, J., Wang, L. Y., Lu, S. N., ... & Chen, C. J. (2017). Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. International Journal of Cancer, 141(4), 711–720. https://doi.org/10.1002/ijc.30782

Davwar, P., David, P., Imoh, L., Duguru, M., Zawaya, K., Tsok, Y., ... & Okeke, E. (2023). Aflatoxin exposure in a population of HIV patients at risk of hepatocellular carcinoma North-Central, Nigeria. African Health Sciences, 23(2), 81–87. https://pmc.ncbi.nlm.nih.gov/articles/PMC10782315/

Downs, L. O., Campbell, C., Yonga, P., Githinji, G., Ansari, M. A., Matthews, P. C., & Etyang, A. O. (2023). A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy. PLOS Global Public Health, 3(1), e0001165. https://doi.org/10.1371/journal.pgph.0001165

Fouad, A. M., Ruan, D., El-Senousey, H. K., Chen, W., Jiang, S., & Zheng, C. (2019). Harmful effects and control strategies of aflatoxin B1 produced by Aspergillus flavus and Aspergillus parasiticus strains on poultry. Toxins, 11(3), 176. https://doi.org/10.3390/toxins11030176

Githang'a, D., Wangia, R. N., Mureithi, M. W., Wandiga, S. O., Mutegi, C., Ogutu, B., ... & Anzala, O. (2019). The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children. Current Problems in Pediatric and Adolescent Health Care, 49(5), 117–130. https://www.sciencedirect.com/science/article/pii/S1538544219300392

Guo, B. Z., Widstrom, N. W., Lee, D. R., Wilson, D. M., & Coy, A. E. (2005). Prevention of preharvest aflatoxin contamination: integration of crop management and genetics in corn. In Aflatoxin and food safety (pp. 462-483). CRC press.https://www.taylorfrancis.com/chapters/edit/10.1201/9781420028171-27/prevention-preharvest-aflatoxin-contamination-integration-crop-management-genetics-corn-baozhu-guo-neil-widstrom-dewey-lee-david-wilson-anton-coy

Inoue, T., & Tanaka, Y. (2016). Hepatitis B virus and its sexually transmitted infection—An update. Microbial Cell, 3(9), 420. https://pmc.ncbi.nlm.nih.gov/articles/PMC5354569/

International Agency for Research on Cancer. (1993). Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins (IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans, Vol. 56). World Health Organization. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Naturally-Occurring-Substances-Food-Items-And-Constituents-Heterocyclic-Aromatic-Amines-And-Mycotoxins-1993

International Agency for Research on Cancer. (2012). Aflatoxins (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100F). World Health Organization. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Aflatoxins-2012

Jepkemei, K. B., Ochwoto, M., Swidinsky, K., Day, J., Gebrebrhan, H., McKinnon, L. R., ... & Osiowy, C. (2020). Characterization of occult hepatitis B in high-risk populations in Kenya. PLOS ONE, 15(5), e0233727. https://doi.org/10.1371/journal.pone.0233727

Kensler, T. W., Roebuck, B. D., Wogan, G. N., & Groopman, J. D. (2011). Aflatoxin: A 50-year odyssey of mechanistic and translational toxicology. Toxicological Sciences, 120(S1), S28–S48. https://doi.org/10.1093/toxsci/kfq283

Kenya National Bureau of Statistics. (2021). Economic survey 2021. Government of Kenya. https://www.knbs.or.ke

Kew, M. C. (2013). Hepatocellular carcinoma in developing nations: Aflatoxin, cirrhosis and viral hepatitis. South African Gastroenterology Review, 11(2), 9–11. https://doi.org/10.1080/1812541X.2013.10865078

Kimani, P. M., Kombe, Y., Wamunyokoli, F. W., Mbakaya, C. F., & Gathumbi, J. K. (2019). The additive effect of Hepatitis B Virus and Aflatoxin B1 to liver disease burden: A case study in Kitui, Makueni and Machakos Counties, Kenya. Journal of Health and Medical Sciences, 2(3). https://doi.org/10.31295/jhms.v2n3.134

Kumi, J. (2015). Aflatoxin levels in adults with viral hepatitis infection in the Ejura-Sekyedumase District of Ghana (Doctoral dissertation, University of Ghana). UGSpace. https://ugspace.ug.edu.gh/handle/123456789/12345

Liu, X., Baecker, A., Wu, M., Zhou, J. Y., Yang, J., Han, R. Q., ... & Zhang, Z. F. (2019). Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population. Liver International, 39(8), 1490–1503. https://doi.org/10.1111/liv.14132

Liu, Y., & Wu, H. (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environmental Health Perspectives, 118(6), 818–824. https://doi.org/10.1289/ehp.0901388

Mak, D., & Kramvis, A. (2021). Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa. Hepatoma Research, 7(39), 26. https://doi.org/10.20517/2394-5079.2021.32

Makokha, G. N., Zhang, P., Hayes, C. N., Songok, E., & Chayama, K. (2023). The burden of Hepatitis B virus infection in Kenya: A systematic review and meta-analysis. Frontiers in Public Health, 11, 986020. https://doi.org/10.3389/fpubh.2023.986020

Mamo, M., Abera, B., Terefe, Y., & Asfaw, M. (2020). Aflatoxin contamination of maize and groundnut in Ethiopia: A systematic review and meta-analysis. Food Control, 108, 106805. https://doi.org/10.1016/j.foodcont.2019.106805

Mekuria, A., Xia, L., Ahmed, T. A., Bishaw, S., Teklemariam, Z., Nedi, T., ... & Gong, Y. Y. (2023). Contribution of aflatoxin B1 exposure to liver cirrhosis in Eastern Ethiopia: A case-control study. International Journal of General Medicine, 16, 3543–3553. https://doi.org/10.2147/IJGM.S410678

Melaram, R. (2021). Environmental risk factors implicated in liver disease: A mini-review. Frontiers in Public Health, 9, 683719. https://doi.org/10.3389/fpubh.2021.683719

Moreno-León, C., & Aguayo, F. (2025). Cooperation between aflatoxin-induced p53 aberrations and hepatitis B virus in hepatocellular carcinoma. Journal of Xenobiotics, 15(4), 96. https://doi.org/10.3390/jox15040096

Negash, D. (2018). A review of aflatoxin: Occurrence, prevention, and gaps in both food and feed safety. Journal of Applied Microbiological Research, 1(1), 35–43.

Niu, Y., Fan, S., Luo, Q., Chen, L., Huang, D., Chang, W., ... & Shi, G. (2021). Interaction of hepatitis B virus X protein with the pregnane X receptor enhances the synergistic effects of aflatoxin B1 and hepatitis B virus on promoting hepatocarcinogenesis. Journal of Clinical and Translational Hepatology, 9(4), 466. https://doi.org/10.14218/JCTH.2021.00044

Ochwoto, M., Kimotho, J. H., Oyugi, J., Odoyo, E. M., Ochieng, W., Ouso, L., ... & Kramer, M. R. (2016). Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya. BMC Infectious Diseases, 16(1), 101. https://doi.org/10.1186/s12879-016-1441-2

Okoth, S., Nyongesa, B., Ayugi, V., Kang'ethe, E., & Koroti, E. (2012). Natural occurrence of mycotoxins in maize and sorghum in Uasin Gishu County, Kenya. African Journal of Food, Agriculture, Nutrition and Development, 12(6), 6659–6672. https://doi.org/10.4314/ajfand.v12i6.12

Osano, O., Chelimo, S. J., Isaboke, J., & Menya, D. (2021). Aflatoxin B1 quantification from fish feeds and fishery products in Kisumu and Uasin Gishu Counties, Kenya. Africa Environmental Review Journal, 4(2), 61–72.

Parikh, P., Ryan, J. D., & Tsochatzis, E. A. (2017). Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Annals of Translational Medicine, 5(3), 40. https://doi.org/10.21037/atm.2017.01.08

Polpichai, N., Saowapa, S., Danpanichkul, P., Chan, S. Y., Sierra, L., Blagoie, J., ... & Kaewdech, A. (2024). Beyond the liver: A comprehensive review of strategies to prevent hepatocellular carcinoma. Journal of Clinical Medicine, 13(22), 6770. https://doi.org/10.3390/jcm13226770

Probst, C., Njapau, H., & Cotty, P. J. (2007). Outbreak of an acute aflatoxicosis in Kenya in 2004: Identification of the causal agent. Applied and Environmental Microbiology, 73(8), 2762–2764. https://doi.org/10.1128/AEM.02342-06

Sagnelli, E., Macera, M., Russo, A., Coppola, N., & Sagnelli, C. (2020). Epidemiological and etiological variations in hepatocellular carcinoma. Infection, 48, 7–17. https://doi.org/10.1007/s15010-019-01345-y

Shephard, G. S. (2003). Aflatoxin and food safety: Recent African perspectives. Toxin Reviews, 22(2–3), 267–286. https://doi.org/10.1081/TXR-120024089

Shephard, G. S. (2019). Current status of mycotoxin analysis: A critical review. Analytical and Bioanalytical Chemistry, 411(1), 1–15. https://doi.org/10.1007/s00216-018-1423-9

Songtanin, B., Chaisrimaneepan, N., Mendóza, R., & Nugent, K. (2024). Burden, outcome, and comorbidities of extrahepatic manifestations in hepatitis B virus infections. Viruses, 16(4), 618. https://doi.org/10.3390/v16040618

Suresh, M., & Menne, S. (2021). Application of the woodchuck animal model for the treatment of hepatitis B virus-
induced liver cancer. World Journal of Gastrointestinal Oncology, 13(6), 509. https://doi.org/10.4251/wjgo.v13.i6.509

Wahome, P. K., Kiende, P., Nakazea, R. J., Mwasowa, N. M., & Nyamu, G. W. (2022). Occult hepatitis B virus infections and risk factors among school-going adolescent voluntary blood donors in Kwale County Kenya, January 2020–June 2021: Cross sectional study. PLOS ONE, 17(7), e0263473. https://doi.org/10.1371/journal.pone.0263473

Wang, P., Wang, Y., Feng, T., Yan, Z., Zhu, D., Lin, H., ... & Shen, Y. (2023). Hedyotis diffusa alleviate aflatoxin B1-induced liver injury in ducks by mediating Nrf2 signaling pathway. Ecotoxicology and Environmental Safety, 249, 114339. https://doi.org/10.1016/j.ecoenv.2023.114339

Wangia, R. N. (2020). Mycotoxin exposures in children (Doctoral dissertation, University of Georgia). UGA Repository.

Wild, C. P., & Gong, Y. Y. (2010). Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis, 31(1), 71–82. https://doi.org/10.1093/carcin/bgp264

Wild, C. P., & Turner, P. C. (2002). The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis, 17(6), 471–481. https://doi.org/10.1093/mutage/17.6.471

Williams, J. H., Phillips, T. D., Jolly, P. E., Stiles, J. K., Mixon, C. A., & Winzeler, G. (2004). Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions. American Journal of Clinical Nutrition, 80(5), 1106–1122.

World Health Organization. (2021). Hepatitis B (Fact Sheet). https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

Younossi, Z. M., Wong, G., Anstee, Q. M., & Henry, L. (2023). The global burden of liver disease. Clinical Gastroenterology and Hepatology, 21(8), 1978–1991. https://doi.org/10.1016/j.cgh.2023.03.032

Zampino, R., Boemio, A., Sagnelli, C., Alessio, L., Adinolfi, L. E., Sagnelli, E., & Coppola, N. (2015). Hepatitis B virus burden in developing countries. World Journal of Gastroenterology, 21(42), 11941–11953. https://doi.org/10.3748/wjg.v21.i42.11941

Zaterka, F., & Eisig, J. N. (2016). Aflatoxin and hepatocellular carcinoma. Arquivos de Gastroenterologia, 53(4), 227–228. https://doi.org/10.1590/S0004-28032016000400001

Zhang, Q., Peng, H., Liu, X., Wang, H., Du, J., Luo, X., ... & Hu, P. (2021). Chronic hepatitis B infection with low level viremia correlates with the progression of the liver disease. Journal of Clinical and Translational Hepatology, 9(6), 850. https://doi.org/10.14218/JCTH.2021.00203